Cargando…
TP53-Mutated Myelodysplasia and Acute Myeloid Leukemia
TP53-mutated myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) form a distinct and heterogeneous group of myeloid malignancies associated with poor outcomes. Studies carried out in the last years have in part elucidated the complex role played by TP53 mutations in the pathogenesis of t...
Autores principales: | Testa, Ugo, Castelli, Germana, Pelosi, Elvira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332352/ https://www.ncbi.nlm.nih.gov/pubmed/37435040 http://dx.doi.org/10.4084/MJHID.2023.038 |
Ejemplares similares
-
Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias
por: Testa, Ugo, et al.
Publicado: (2020) -
Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy
por: Castelli, Germana, et al.
Publicado: (2017) -
Genetic, Phenotypic, and Clinical Heterogeneity of NPM1-Mutant Acute Myeloid Leukemias
por: Testa, Ugo, et al.
Publicado: (2023) -
The Growing Role of the BH3 Mimetic Drug Venetoclax in the Therapy of Acute Myeloid Leukemia
por: Pelosi, Elvira, et al.
Publicado: (2022) -
CD123 a Therapeutic Target for Acute Myeloid Leukemia and Blastic Plasmocytoid Dendritic Neoplasm
por: Pelosi, Elvira, et al.
Publicado: (2023)